Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04680689Completed

Assessment of Lesion-Associated Myocardial Ischemia Based on Fusion Coronary CT Imaging

Role: collaborator

NCT03830944Completed

Inflammation-mediated Coronary Plaque Vulnerability, Myocardial Viability and Ventricular Remodeling

Role: collaborator

NCT04397198Completed

The Assessment Of Myocardial Viability Based On CTA/MRI Hybrid Models

Role: collaborator

NCT03511573Completed

ROLIVER - Prospective Cohort for the Identification of Liver Microbiota

Role: lead

All 4 trials loaded